#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Advanced systemic mastocytosis Metastases to peritoneum Vascular malformation Osteosarcoma Dupuytren's contracture Inborn error of metabolism Peritoneal neoplasm Peripheral primitive neuroectodermal tumour of soft tissue Neonatal alloimmune thrombocytopenia Oesophageal adenocarcinoma Neuroendocrine carcinoma Castleman's disease Oropharyngeal cancer recurrent Muscular dystrophy Rheumatoid arthritis More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome Haemophilia A with anti factor VIII – Basic Information Antithrombin III deficiency – Trials in Disease Combined immunodeficiency – Diagnostics Turner’s syndrome – Diagnostics Propionic acidaemia – Diagnostics Primary immunodeficiency syndrome – Life with Disease Retinitis pigmentosa – Basic Information Cytokine release syndrome Methylmalonic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RUBIDIUM CHLORIDE Pimavanserin Tartrate Bemcentinib [11C]Az14193391 Mk-4830 Dextran 70 Eptinezumab Nirogacestat Hydrobromide Nnc0194-0499 Giroctocogene Fitelparvovec Progesterone, Micronised Cedazuridine Dactinomycin Clavulanic Acid Latozinemab LY3537031 Mk-0482 [14C] DC-806 TORASEMIDE Psma-11 More therapies…

    Learn about Your Condition

    Colour blindness Plasma cell myeloma Colorectal cancer stage IV Hot flush Cardiac arrest Pancreatitis chronic Micrographic skin surgery Rosai-Dorfman syndrome Catatonia Dengue fever Dysmenorrhoea Diabetic retinopathy Acromegaly Oesophageal disorder Heart transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of anakinra and a drug combination to prevent blood clots in patients receiving a pancreatic transplant

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Etanercept
    • Anakinra
    • Mycophenolic Acid
    France

  • Psilocybin and pimavanserin for adults with major depressive disorder

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Psilocybine
    Spain

  • OM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Valaciclovir
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria

  • Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Austria Belgium Croatia Czechia Hungary Lithuania +1

  • Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune-mediated myositis
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    Austria Belgium Czechia Finland France Germany +7

  • Study of Ipilimumab and Nivolumab with or without Radiotherapy for Patients with Melanoma Brain Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Italy
Previous Page
1 … 909 910 911 912 913 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!